However, in our study, univariate analysis showed that TOP2A protein ≥ 70% was associated with better OS for the whole cohort of nodal PTCL patients and worse prognosis for the PTCL-NOS subgroup. This evidence concerns the gene TOP2A and mature T-cell and NK-cell non-Hodgkin lymphoma.